Artificial Intelligence in Diabetes Management Market, By Type, By Application, By Deployment, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
Artificial intelligence in diabetes management market size was valued at USD 21,234 Million in 2023, expanding at a CAGR of 38.5% from 2024 to 2032.
Artificial intelligence (AI) in diabetes management uses advanced algorithms and data-driven insights to monitor, predict, and optimize patient care. By analyzing blood glucose patterns, diet, exercise, and lifestyle data, AI systems offer personalized recommendations for medication dosing, dietary adjustments, and activity levels. This technology improves real-time decision-making, enhances glycemic control, and helps healthcare providers deliver proactive, efficient, and patient-specific diabetes management, ultimately reducing complications and promoting healthier outcomes.
Artificial Intelligence in Diabetes Management Market- Market Dynamics
Increasing prevalence of diabetes and technological advancements in AI to propel market demand
The global increase in diabetes cases fuels demand for AI-driven solutions in disease management. In 2021, the International Diabetes Federation reported 537 million adults with diabetes, a figure expected to reach 783 million by 2045. This surge amplifies the need for advanced, AI-enabled diabetes management tools. Besides, improved AI and machine learning capabilities drive the growth of AI in diabetes management market. However, the significant costs of deploying AI systems in healthcare act as a barrier. On the contrary, the global healthcare reforms and government initiatives are supporting AI-driven diabetes care, thereby boosting opportunities for the market.
Artificial Intelligence in Diabetes Management Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 38.5% over the forecast period (2024-2032)
Based on type segmentation, diagnostics was predicted to show maximum market share in the year 2023
Based on application segmentation, type 2 diabetes was the leading type in 2023
Based on deployment segmentation, cloud-based was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
Artificial Intelligence in Diabetes Management Market- Segmentation Analysis:
The Global Artificial Intelligence in Diabetes Management Market is segmented on the basis of Type, Application, Deployment, End User, and Region.
The market is divided into four categories based on type: treatment planning, diagnostics, patient self-management, and diagnostics. The diagnostics sector dominates the market. This growth can be attributed to the the rising prevalence of diabetes and the growing emphasis on early detection.
The market is divided into three categories based on application: gestational diabetes, type 1 diabetes, and type 2 diabetes. The type 2 diabetes sector dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increasing prevalence of type 2 diabetes compared to type 1 diabetes.
Artificial Intelligence in Diabetes Management Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Artificial Intelligence in Diabetes Management Market- Competitive Landscape:
The global market is expanding due to increased adoption of AI-driven tools for precise, data-oriented diabetes care. Companies in this market are focusing on partnerships with healthcare providers to integrate AI into existing diabetes monitoring systems, enabling real-time blood glucose analysis and personalized recommendations. Additionally, firms are investing in advanced AI algorithms to enhance predictive capabilities, facilitating early intervention and optimized treatment regimens to improve patient outcomes.
Recent Developments:
In March 2024, Roche introduced the AI-powered diabetes tracker, Accu-Chek SmartGuide, which uses real-time continuous glucose monitoring to predict blood sugar fluctuations up to two hours ahead.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Eli Lilly and Company
Johnson & Johnson
Tandem Diabetes Care
AstraZeneca
Sanofi
BD
Insulet
Bayer
Novo Nordisk
Ypsomed
Medtronic
Dexcom
Merck & Co. Inc.
Abbott
Bigfoot Biomedical, Inc.
Crayon Group
Cardinal Health Inc.
DreaMed Diabetes, Ltd.
Eyenuk, Inc.
Glooko SAS
F. Hoffmann-La Roche Ltd.
HCL Technologies Limited
Medtronic PLC
International Business Machines Corporation
Virta Health Corp.
Others
GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
Treatment Planning
Data Management
Diagnostics
Patient Self-management
GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Gestational Diabetes
Type 1 Diabetes
Type 2 Diabetes
GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY DEPLOYMENT- MARKET ANALYSIS, 2019 - 2032
Software as a Service (SaaS)
On-premise
Cloud-based
GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
Ambulatory Surgical Centers
Hospitals & Clinics
Patients
Diabetes Treatment Centers
GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
1. Artificial Intelligence in Diabetes Management Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Artificial Intelligence in Diabetes Management Market Snippet by Type
2.1.2. Artificial Intelligence in Diabetes Management Market Snippet by Application
2.1.3. Artificial Intelligence in Diabetes Management Market Snippet by Deployment
2.1.4. Artificial Intelligence in Diabetes Management Market Snippet by End User
2.1.5. Artificial Intelligence in Diabetes Management Market Snippet by Country
2.1.6. Artificial Intelligence in Diabetes Management Market Snippet by Region
2.2. Competitive Insights
3. Artificial Intelligence in Diabetes Management Key Market Trends
3.1. Artificial Intelligence in Diabetes Management Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Artificial Intelligence in Diabetes Management Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Artificial Intelligence in Diabetes Management Market Opportunities
3.4. Artificial Intelligence in Diabetes Management Market Future Trends
4. Artificial Intelligence in Diabetes Management Industry Study
4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Artificial Intelligence in Diabetes Management Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Artificial Intelligence in Diabetes Management Market Landscape
6.1. Artificial Intelligence in Diabetes Management Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players' Analysis
6.2.2. Emerging Players' Analysis
7. Artificial Intelligence in Diabetes Management Market - By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
7.1.2. Treatment Planning
7.1.3. Data Management
7.1.4. Diagnostics
7.1.5. Patient Self-management
8. Artificial Intelligence in Diabetes Management Market - By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
8.1.2. Gestational Diabetes
8.1.3. Type 1 Diabetes
8.1.4. Type 2 Diabetes
9. Artificial Intelligence in Diabetes Management Market - By Deployment
9.1. Overview
9.1.1. Segment Share Analysis, By Deployment, 2023 & 2032 (%)
9.1.2. Software as a Service (SaaS)
9.1.3. On-premise
9.1.4. Cloud-based
10. Artificial Intelligence in Diabetes Management Market - By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
10.1.2. Ambulatory Surgical Centers
10.1.3. Hospitals & Clinics
10.1.4. Patients
10.1.5. Diabetes Treatment Centers
11. Artificial Intelligence in Diabetes Management Market- By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Artificial Intelligence in Diabetes Management Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)